ABUS

#2156
Arbutus Biopharma Corporation Common Stock
4.66
-0.64%
Secteur:
Base:
Devise de Profit:
Range quotidien
4.66
4.66
Range Annuel
2.71
5.10
Changement quotidien
-0.64%
Changement Mensuel
+11.75%
Evolution sur 6 mois
+27.32%
Changement Annuel
+38.69%
Clôture Précédente
4.69
Open
4.66
Bid
Ask
Low
4.66
High
4.66
Volume
230
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Nouvelles